Figure 5

Anti-tumour efficacy of nanogel vaccines. (a) Tumour volume of C57BL/6J mice inoculated E.G7-OVA cells, vaccinated PBS as control (cross), OVA (square), OVA/CHP (open circle) or OVA/CH-CDex (closed circle) on 5 and 9 days after tumour inoculation. (b) Tumour volume of each mice and (c) survival rate of each group.